Amsterdam, Netherlands – 28 Aug 2023: Minimising atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late breaking research presented in a Hot Line ...

Minimizing atrial pacing does not prevent atrial fibrillation in patients with sinus node dysfunction, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

The US Food and Drug Administration (FDA) has given Breakthrough Device Designation to Orchestra BioMed for its atrioventricular interval modulation (AVIM) therapy for patients with uncontrolled ...